Citation Impact
Citing Papers
Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients
2008
The Protective Effect of Interleukin-37 on Vascular Calcification and Atherosclerosis in Apolipoprotein E-Deficient Mice with Diabetes
2015
The emerging roles of PAF acetylhydrolase
2008
Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
2009 StandoutNobel
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis
2007 Standout
LOX-1/LOXIN: The Yin/Yang of Atheroscleorosis
2011
Phospholipase A2 subclasses in acute respiratory distress syndrome
2009
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis
2016
Monocyte recruitment during infection and inflammation
2011 Standout
The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptors
2008
Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: Role of reactive oxygen species
2007
Biochemistry and cell biology of mammalian scavenger receptors
2005
Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity
2022 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor‐α in human aortic smooth muscle and embryonic kidney cells
2006
The metabolic syndrome
2010 Standout
Marine natural products
1990 Standout
Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): A critical player in the development of atherosclerosis and related disorders
2005 Standout
The Lifelong Effects of Early Childhood Adversity and Toxic Stress
2011 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
2010 Standout
Associations of low density lipoprotein particle composition with atherogenicity
2004
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways
2009 StandoutNobel
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Pharmacological and Clinical Aspects of Heme Oxygenase
2008
Pleiotropic effects of thiazolidinediones: Taking a look beyond antidiabetic activity
2004
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
2009 Standout
Dual Roles of Endogenous Platelet-Activating Factor Acetylhydrolase in a Murine Model of Necrotizing Enterocolitis
2010
The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells
2008
Evaluating the Toxicity of Airborne Particulate Matter and Nanoparticles by Measuring Oxidative Stress Potential—A Workshop Report and Consensus Statement
2008
Nonresolving Inflammation
2010 Standout
Role of transforming growth factor-β superfamily signaling pathways in human disease
2008
Upregulation of lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human endothelial cells by modified high density lipoproteins
2012
Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation
2006
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
2007
OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling
2010
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
The metabolic syndrome
2005 Standout
A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro
2009
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
2020 Standout
LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma
2009
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
2012
AT2 receptors: Functional relevance in cardiovascular disease
2008
Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances
2006
Effects of PTH treatment on tibial bone of ovariectomized rats assessed by in vivo micro-CT
2009
Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort
2009
LOX-1 Receptor Blockade Abrogates oxLDL-induced Oxidative DNA Damage and Prevents Activation of the Transcriptional Repressor Oct-1 in Human Coronary Arterial Endothelium
2008
Serum malondialdehyde level: Surrogate stress marker in the Sikkimese diabetics
2011
Role of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the development of hypertensive organ damage
2004
10 Years of GWAS Discovery: Biology, Function, and Translation
2017 Standout
Regulatory role of endothelium in the expression of genes affecting arterial calcification
2004
The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization
2008
GATES: A Rapid and Powerful Gene-Based Association Test Using Extended Simes Procedure
2011
Sirt1 plays an important role in mediating greater functionality of human ES/iPS-derived vascular endothelial cells
2010 StandoutNobel
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
2007
LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells
2009
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
2014
Hyperlipidemia: a new therapeutic target for diabetic neuropathy
2009
Scara1 deficiency impairs clearance of soluble amyloid-β by mononuclear phagocytes and accelerates Alzheimer’s-like disease progression
2013
The therapeutic potential of carbon monoxide
2010 Standout
LOX-1 and Angiotensin Receptors, and Their Interplay
2011
Fatty acids differentially influence phosphatidylinositol 3-kinase signal transduction in endothelial cells: Impact on adhesion and apoptosis
2007
Cytokines and atherosclerosis: a comprehensive review of studies in mice
2008
Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology
2009
Small Concentrations of oxLDL Induce Capillary Tube Formation From Endothelial Cells via LOX-1–Dependent Redox-Sensitive Pathway
2007
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
The Antifibrogenic Potential of PPARγ Ligands in Pulmonary Fibrosis
2008
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice
2015
Aldosterone mediates angiotensin II‐induced interstitial cardiac fibrosis via a Nox2‐containing NADPH oxidase
2006
Ox-LDL plays dual effect in modulating expression of inflammatory molecles through LOX-1 pathway in human umbilical vein endothelial cells
2005
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling
2010
In Vivo and In Vitro Studies Support That a New Splicing Isoform of OLR1 Gene Is Protective Against Acute Myocardial Infarction
2005
Diabetic Cardiomyopathy
2018 Standout
The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
2021
LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia–reperfusion
2007
Immune and Inflammatory Mechanisms of Atherosclerosis
2009
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction.
2009
Alternative Activation of Macrophages: An Immunologic Functional Perspective
2008 Standout
LOX-1, OxLDL, and Atherosclerosis
2013 Standout
Molecular characterization of foveal versus peripheral human retina by single-cell RNA sequencing
2019
Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1
2011
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Interleukin‐10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice
2010
A Candidate Gene Study Revealed Sex-Specific Association Between the OLR1 Gene and Carotid Plaque
2011
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Oxidized LDL Receptor LOX-1 Binds to C-Reactive Protein and Mediates Its Vascular Effects
2008
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
2013 Standout
Mechanisms of Diabetic Complications
2013 Standout
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension
2015
Guidelines for assessment of bone microstructure in rodents using micro–computed tomography
2010 Standout
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
The Metabolic Syndrome
2008 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis
2017
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Circulating Platelet-Activating Factor Is Primarily Cleared by Transport, Not Intravascular Hydrolysis by Lipoprotein-Associated Phospholipase A 2 / PAF Acetylhydrolase
2010
Vascular Calcification
2006 Standout
The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease
2012
Comparison of the Mechanism of Toxicity of Zinc Oxide and Cerium Oxide Nanoparticles Based on Dissolution and Oxidative Stress Properties
2008 Standout
The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease
2007
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of Jiawei Chen being referenced
Inhibitory Effect of Candesartan and Rosuvastatin on CD40 and MMPs Expression in Apo-E Knockout Mice
2004
Cross-talk between dyslipidemia and renin–angiotensin system and the role of LOX-1 and MAPK in atherogenesis
2005
Genome-wide gene-based association study
2009
Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque
2007
Interaction of oxidized low-density lipoprotein and the renin-angiotensin system in coronary artery disease
2006
miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer
2016
Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10
2005
EPA and DHA attenuate ox-LDL-induced expression of adhesion molecules in human coronary artery endothelial cells via protein kinase B pathway
2003
LOX-1 abrogation reduces myocardial ischemia–reperfusion injury in mice
2007
Suppression of atherogenesis by delivery ofTGF β 1 ACT
2006
Modulation of ADP-Induced Platelet Activation by Aspirin and Pravastatin: Role of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1, Nitric Oxide, Oxidative Stress, and Inside-Out Integrin Signaling
2007
Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone
2006
Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis
2007
Adhesion Molecule Expression in Fibroblasts
2005
Pioglitazone Inhibits LOX-1 Expression in Human Coronary Artery Endothelial Cells by Reducing Intracellular Superoxide Radical Generation
2003
Role of oxidative stress in coronary heart disease.
2004
Role of Caspases in Ox-LDL–Induced Apoptotic Cascade in Human Coronary Artery Endothelial Cells
2003
Angiotensin II Regulation of Collagen Type I Expression in Cardiac Fibroblasts
2004
Molecular Dissection of Angiotensin II–Activated Human LOX-1 Promoter
2006
Effect of intermittent injection of recombinant human parathyroid hormone on bone histomorphometry of ovariectomized rats.
2002
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis
2005
Deletion of LOX-1 Reduces Atherogenesis in LDLR Knockout Mice Fed High Cholesterol Diet
2007
Long non-coding RNA MIAT acts as a biomarker in diabetic retinopathy by absorbing miR-29b and regulating cell apoptosis
2017